Pneumocytis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya

East African Medical Journal

Volumn 80, Issue 1, 2003, Pages 30-35

  Chakaya, J M ^a   Bii, C ^a   Ng'Ang'a, L ^a   Amukoye, E ^a   Ouko, T ^a   Muita, L ^a   Gathua, S ^b   Gitau, J ^a   Odongo, I ^c   Kabanga, J M ^a   Nagai, K ^d   Suzumura, S ^e   Sugiura, Y ^f  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Menelik Medical Centre   (Kenya)

^c Mbagathi District Hospital   (Kenya)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Teine Keijinkai Hospital   (Japan)

^f NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; BRONCHOSCOPY; FEMALE; HUMAN; KENYA; MALE; MIDDLE AGED; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; URBAN POPULATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRONCHOSCOPY; FEMALE; HUMANS; KENYA; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; URBAN POPULATION;

EID: 0038340134     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ellvin, K.M., Lumbwe, C.M., Luo, N.P., Bjorkman, A., Kallenius, G. and Linder, E. Pneumocytis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka Zambia. Trans. Roy. Soc. Trop. Med. & Hyg. 1989; 83:553-555.
2. Lucas, S.B., Goodgame, R., Koejan, G. and Serwadda, D. Absence of pneumocytosis in Ugandan AIDS patients. AIDS. 1989; 3:47-48.
3. Lucas, S.B. Missing Infections in AIDS. Trans. Roy. Soc. Trap. Med. & Hyg. 1990; 84(Supp/1):34-38.
4. Lucas, S.B., Odida, M. and Wabinga, H. The pathology of severe morbidity and mortality caused by HIV infection in Africa. AIDS. 1991; 5(Suppl 1):S143-S148.
5. Carme, J., Mboussa, J.M., Andzin, M., Mbouni, P., Mpele, P. and Dairy, A. Pneumocytis carinii is rare in AIDS in Central Africa. Trans. Roy. Trop. Med & Hyg. 1991; 85:80.
6. Abouya, Y., Beaumel, A., Lucas, S., et al. Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Ame. Rev. Respir. Dis. 1992; 145:617-620.
7. Masur, R., Micheles, M.A., Greene, J. et al. An outbreak of community acquired Pneumocytis carinii Pneumonia: Initial manifestation of acquired cellular immune dysfunction. 1981; 305:1431-4383.
8. Gottlieb, M.S., Schroff, R., Shanker, H.M. Pneumocytis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. New Eng. J. Med. 1981; 305: 1425-1431.
9. Update: acquired immunodeficiency syndrome-United States. MMWR Morb. Mortal Wkly. Rep. 1986; 35:757-766.
10. Update: acquired immunodeficiency syndrome-United States. MMWR Morb Mortal Wkly Rep 1986; 35:17-21.
11. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infection in persons infected with human immunodeficiency virus: disease specific recommendations. Clin. Infect. Dis. 1997; 25(suppl)3:S313-S335.
12. Thijis, A. and Janssens, P. Pneumocytosis in Congolese infants. Trop. Geogr. Med. 1963; 15:158-172.
13. Bwibo, N. and Owor, R. Pneumocystis carinii pneumonia in Ugandan African children. W. Afr. Med. J. 1970; 19: 184-185.
14. Lesley G. and Lucas, S.B. Does Pneumocytis carinii occur in Kenya. Trans. Roy. Soc. Trop. Med & Hyg. 1982; 76:198-199.
15. Adam, S.M., Lovemore, K.Z.G., Susanne, K. et al. Pneiimocytis carinii pneumonia in Zimbabwe. Lancet 1995; 346:1258-1261.
16. David, A. R. and Joseph, A.K. Pneumocytis carini in Africa an emerging pathogen? Commentary. Lancet. 1995; 346:1242-1243.
17. Rana, H., M.P., Meme, H.K., Chakaya, J.M. et al. Autopsy findings in HIV-1 infected adults in Kenya (Letter). J. Acq. Imm. Defi. Syndro. Human Retrov. 1997; 14: 83-85.
18. Gosey, L.L., Howard, R.M., Whebsky, F.G. et al. Advantages of modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of pneumocytis carinii pneumonia. J. Clin. Microbiol. 1985; 22:303-807.
19. Madeod, D.T., Neil, P., Robertson, U.J. et al. Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans. Roy. Soc. Trop. Med & Hyg. 1989; 83:94-697.
20. Xavier, A., Genevieve, C., Alain, A. et al. Early chemoprophylaxis with trimethoprim sulphamethoxazole for HIV 1 infected adults in Abdijan. Cote d'Ivoire: a randomised trial. Lancet. 1999; 353:1463-1168.
21. Stefan, Z.W., Madeleine, S.M., Allison, D. et al. Efficacy of trimethoprim sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV 1 infected patients with tuberculosis in Abdijan, Cote d'Ivoire: a randomised controlled trial. Lancet. 1999; 353:1469-1475.
22. Badri, M., Ehrlich, R., Wood, R. and Maartens, G. Initiating co-trimoxazole prophylaxis m HIV infected patients in Africa; an evaluation of the provisional WHO/UNAIDS recommendations. AIDS. 2001; 15:1143-1148.
23. Robert F. M. and David, M. Pneumocytis carinii pneumonia. Thorax. 1995; 50:191-200.